MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET 2021-2028

Lifesciences | Diagnostic & Biotechnology

MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET 2021-2028

Market by Gender, End-user, and Country | Forecast 2021-2028

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton’s research report suggests the infertility testing and treatment market in the Middle East and Africa is likely to witness growth at a compound annual growth rate of 9.43% during the years 2021-2028.


Report scope can be customized per your requirements. Request For Customization

The countries considered for analysis in this market are:

•        The United Arab Emirates

•        Turkey

•        South Africa

•        Saudi Arabia

•        Rest of Middle East & Africa

In the region, IVF is a widely accepted infertility treatment in the clinical industry. The government initiatives for developing the healthcare infrastructure, rising lifestyle and hormonal disorders, and declining rates of pregnancies are supporting the growth of IVF treatments across the region’s nations. This will ultimately contribute to the growth of the infertility testing and treatment market across the region.

In the United Arab Emirates, there has been a major decline in fertility rates, owing to high levels of diabetes and polycystic ovary syndrome. These conditions create a hormonal imbalance, making conceiving a major challenge. Although there are strict laws against surrogacy, the country permits fertility treatments under sharia law. Moreover, the government is encouraging IVF treatment owing to the rise in infertility rates. Hence, the supportive government laws are estimated to supplement the growth of the infertility testing and treatment market across the UAE.

Furthermore, the growing demand for medical care has made countries like Turkey adopt several policies to encourage and subsidize the international flow of patients. The country is considered to be among the popular medical tourist destinations due to the provision of offering high-level medical facilities at relatively low costs. Therefore, the developing medical sector is likely to open new avenues for the infertility testing and treatment market.

Ferring Pharmaceuticals is a specialty biopharmaceutical group providing innovative products in the fields of reproductive medicine and women’s health, urology, and gastroenterology. Its product line includes Endometrin, a vaginal insert containing hormones for patients requiring high progesterone levels. Ferring has operations around various regions, such as Europe and the Middle East and Africa region. 

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. KEY INSIGHTS

2.1.1. GROWING DEMAND FOR LOW-COST PROCEDURES

2.1.2. INCREASING ACCEPTANCE OF DONOR EGGS

2.1.3. USE OF AI INCREASES THE SUCCESS OF IVF TREATMENT

2.2. IMPACT OF COVID-19 ON INFERTILITY TESTING AND TREATMENT MARKET

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTE

2.3.3. BARGAINING POWER OF SUPPLIERS

2.3.4. BARGAINING POWER OF BUYERS

2.3.5. THREAT OF COMPETITIVE RIVALRY

2.4. KEY BUYING IMPACT ANALYSIS

2.4.1. TREATMENT OPTIONS

2.4.2. QUALITY OF MEDICAL PROCEDURES

2.4.3. PRICE OF TREATMENTS

2.4.4. SHIFT TOWARDS MEDICAL TOURISM

2.4.5. REIMBURSEMENT

2.5. MARKET ATTRACTIVENESS MATRIX

2.6. INDUSTRY COMPONENTS

2.6.1. RAW MATERIAL PROCUREMENT

2.6.2. MANUFACTURING

2.6.3. SUPPLY LOGISTICS

2.6.4. DISTRIBUTION CHANNELS

2.6.5. END-USERS

2.7. VENDOR SCORECARD

2.8. KEY MARKET STRATEGIES

2.8.1. CONTRACTS & PARTNERSHIPS

2.8.2. ACQUISITIONS & MERGERS

2.8.3. NEW PRODUCT LAUNCHES

2.9. MARKET DRIVERS

2.9.1. GROWTH IN STRESS AND LIFESTYLE DISORDERS

2.9.2. RISING TREND IN DELAYED MARRIAGES AND PREGNANCIES

2.9.3. IMPROVEMENTS IN TREATMENTS

2.9.4. GOVERNMENT SUPPORT

2.10. MARKET CHALLENGES

2.10.1. HIGH COST

2.10.2. SOCIAL TABOO PERTAINING TO INFERTILITY

2.10.3. RISKS ASSOCIATED WITH TREATMENTS

2.11. MARKET OPPORTUNITIES

2.11.1. TECHNOLOGY ADVANCEMENTS IN TIME-LAPSE TECHNOLOGY

2.11.2. ADVANCES IN EMBRYO BIOPSY AND GENETIC SCREENING

3. MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET – BY GENDER

3.1. MALE

3.1.1. MALE INFERTILITY TESTING

3.1.1.1. DNA FRAGMENTATION

3.1.1.2. OXIDATIVE STRESS ANALYSIS

3.1.1.3. SPERM PENETRATION ASSAY

3.1.1.4. COMPUTER-ASSISTED SEMEN ANALYSIS (CASA)

3.1.1.5. SPERM AGGLUTINATION

3.1.1.6. MICROSCOPIC EXAMINATION

3.1.1.7. OTHERS

3.1.2. MALE INFERTILITY TREATMENT

3.1.2.1. MEDICATION

3.1.2.2. ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY

3.2. FEMALE

3.2.1. FEMALE INFERTILITY TESTING

3.2.1.1. OVULATION TESTING

3.2.1.2. HYSTEROSALPINGOGRAPHY

3.2.1.3. LAPAROSCOPY

3.2.1.4. TRANSVAGINAL ULTRASOUND

3.2.1.5. OVARIAN RESERVE TESTING

3.2.1.6. HORMONAL LEVEL TESTING

3.2.1.7. OTHERS

3.2.2. FEMALE INFERTILITY TREATMENT

3.2.2.1. IVF WITH ICSI

3.2.2.2. IUI

3.2.2.3. IVF WITHOUT ICSI

3.2.2.4. SURROGACY

3.2.2.5. OTHERS

4. MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET - BY END-USER

4.1. FERTILITY AND SURGICAL CENTERS

4.2. HOSPITALS & RESEARCH LABORATORIES

4.3. CRYOBANKS

5. MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET – REGIONAL OUTLOOK

5.1. UNITED ARAB EMIRATES

5.2. TURKEY

5.3. SAUDI ARABIA

5.4. SOUTH AFRICA

5.5. REST OF MIDDLE EAST & AFRICA

6. COMPETITIVE LANDSCAPE

6.1. ADORFEM

6.2. BANGKOK IVF CENTER

6.3. COOK MEDICAL INC

6.4. COOPER SURGICAL

6.5. CREATE FERTILITY CENTRE

6.6. EMD GROUP (MERCK KGAA)

6.7. ENDO INTERNATIONAL PLC

6.8. FERRING PHARMACEUTICALS

6.9. HALOTECH DNA

6.10. GENEA LTD

6.11. FUJIFILM IRVINE SCIENTIFIC

6.12. VITROLIFE AB

6.13. LABOTECT GMBH

6.14. OLYMPUS CORPORATION

6.15. PROGYNY

7. METHODOLOGY & SCOPE

7.1. RESEARCH SCOPE & DELIVERABLES

7.2. SOURCES OF DATA

7.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 2: MARKET ATTRACTIVENESS MATRIX

TABLE 3: VENDOR SCORECARD

TABLE 4: LIST OF CONTRACTS & PARTNERSHIPS

TABLE 5: LIST OF ACQUISITIONS & MERGERS

TABLE 6: LIST OF NEW PRODUCT LAUNCHES

TABLE 7: AVERAGE COST COMPARISON OF INFERTILITY TREATMENTS

TABLE 8: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY GENDER, 2021-2028 (IN $ MILLION)

TABLE 9: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)

TABLE 10: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

TABLE 11: ROS AND CONS OF DNA SHARING METHODS

TABLE 12: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

TABLE 13: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)

TABLE 14: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

TABLE 15: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

TABLE 16: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 17: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1: PORTER’S FIVE FORCES ANALYSIS

FIGURE 2: KEY BUYING IMPACT ANALYSIS

FIGURE 3: INDUSTRY COMPONENTS

FIGURE 4: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY GENDER, 2020 & 2028 (IN %)

FIGURE 5: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)

FIGURE 6: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE, 2020 & 2028 (IN %)

FIGURE 7: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

FIGURE 8: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2020 & 2028 (IN %)

FIGURE 9: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY DNA FRAGMENTATION, 2021-2028 (IN $ MILLION)

FIGURE 10: CAUSES OF SPERM DNA FRAGMENTATION

FIGURE 11: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY OXIDATIVE STRESS ANALYSIS, 2021-2028 (IN $ MILLION)

FIGURE 12: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY SPERM PENETRATION ASSAY, 2021-2028 (IN $ MILLION)

FIGURE 13: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY COMPUTER-ASSISTED SEMEN ANALYSIS (CASA), 2021-2028 (IN $ MILLION)

FIGURE 14: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY SPERM AGGLUTINATION, 2021-2028 (IN $ MILLION)

FIGURE 15: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY MICROSCOPIC EXAMINATION, 2021-2028 (IN $ MILLION)

FIGURE 16: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)

FIGURE 17: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

FIGURE 18: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2020 & 2028 (IN %)

FIGURE 19: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY MEDICATION, 2021-2028 (IN $ MILLION)

FIGURE 20: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY, 2021-2028 (IN $ MILLION)

FIGURE 21: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)

FIGURE 22: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE, 2020 & 2028 (IN %)

FIGURE 23: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

FIGURE 24: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2020 & 2028 (IN %)

FIGURE 25: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY OVULATION TESTING, 2021-2028 (IN $ MILLION)

FIGURE 26: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY HYSTEROSALPINGOGRAPHY, 2021-2028 (IN $ MILLION)

FIGURE 27: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY LAPAROSCOPY, 2021-2028 (IN $ MILLION)

FIGURE 28: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY TRANSVAGINAL ULTRASOUND, 2021-2028 (IN $ MILLION)

FIGURE 29: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY OVARIAN RESERVE TESTING, 2021-2028 (IN $ MILLION)

FIGURE 30: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY HORMONAL LEVEL TESTING, 2021-2028 (IN $ MILLION)

FIGURE 31: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)

FIGURE 32: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

FIGURE 33: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2020 & 2028 (IN %)

FIGURE 34: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY IVF WITH ICSI, 2021-2028 (IN $ MILLION)

FIGURE 35: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY IUI, 2021-2028 (IN $ MILLION)

FIGURE 36: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY IVF WITHOUT ICSI, 2021-2028 (IN $ MILLION)

FIGURE 37: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY SURROGACY, 2021-2028 (IN $ MILLION)

FIGURE 38: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)

FIGURE 39: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY END-USER, 2020 & 2028 (IN %)

FIGURE 40: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY FERTILITY AND SURGICAL CENTERS, 2021-2028 (IN $ MILLION)

FIGURE 41: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY HOSPITALS & RESEARCH LABORATORIES, 2021-2028 (IN $ MILLION)

FIGURE 42: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, BY CRYOBANKS, 2021-2028 (IN $ MILLION)

FIGURE 43: MIDDLE EAST AND AFRICA INFERTILITY TESTING AND TREATMENT MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 44: UNITED ARAB EMIRATES INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 45: TURKEY INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 46: SAUDI ARABIA INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 47: SOUTH AFRICA INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 48: REST OF MIDDLE EAST & AFRICA INFERTILITY TESTING AND TREATMENT MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;